Cochlear | COH - Market Capitalization

Stock Price
173.14
Daily Change
-0.56 -0.32%
Monthly
-13.40%
Yearly
-35.75%
Q1 Forecast
170.76

Cochlear reported AUD11.37B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 4.72B 1.36B Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Cochlear AUD 13.02B 4.03B Mar/2026
CSL USD 71.32B 15.44B Mar/2026
Fisher Paykel Healthcare NZD 22.48B 720.28M Mar/2026
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Mesoblast USD 1.39B 2.16B Jun/2025
Monash IVF AUD 270.8M 15.59M Mar/2026
Nanosonics AUD 1.04B 168.38M Mar/2026
Polynovo AUD 825.56M 583.76M Jun/2025
Ramsay Health Care AUD 9.45B 1.52B Mar/2026
Regis Healthcare AUD 2.1B 3.2M Mar/2026
ResMed USD 52.52B 14.69B Dec/2025
Sigma Healthcare AUD 2.8B 1.88B Feb/2026
Somnomed AUD 79.04M 27.72M Jun/2023
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025